pharma · Schizophrenia
Guangzhou Psychiatric Hospital
Guangzhou Psychiatric Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Schizophrenia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Olanzapine
Unknown · small molecule · Schizophrenia
Olanzapine for Schizophrenia is a Unknown program (small_molecule) at Guangzhou Psychiatric Hospital with 1 ClinicalTrials.gov record(s).
Internal code Huiai 2014Y2-00105
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Guangzhou Psychiatric Hospital
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Schizophrenia
- Status
- active
- Trials
- 1